Table 6.

Khorana risk assessment model.

Features	Risk score
1. Site of cancer
Very high risk (stomach, pancreas)	2
High risk (lung, lymphoma, gynecologic, bladder, testicular)	1
2. Hb < 10 gm/dL or use of red cell growth factors	1
3. Prechemotherapy leukocyte count > 11 × 109/L	1
4. Prechemotherapy platelet count ≥ 350 × 109/L	1
5. BMI ≥ 35 kg/m2	1

BMI: body mass index.

Risk groups: Low risk = 0, Intermediate risk = 1–2, High risk ≥ 3.